Microsoft (MSFT) stock is trading at $510 after Stifel raised its price target on the shares to $530 from $450 following a meeting between the firm's analyst and company executives this week. Despite the higher target, Stifel maintained its Hold rating rather than upgrading to Buy. That stance is notable given the broader analyst landscape: Microsoft carries a Strong Buy consensus on Wall Street, making Stifel one of the few firms holding back from a Buy-equivalent rating.

Analyst Brad Reback said he sees potential for further upside, but only if conditions change. He does not expect the stock to re-rate unless Azure growth meaningfully re-accelerates or capital spending growth slows below Azure's growth rate. The dynamic reflects a wider investor debate over hyperscaler capital spending, where heavy AI infrastructure investment has pressured free cash flow even as cloud revenue accelerates. Reback's primary concern is competitive pressure: Google is gaining market share, and Microsoft's OpenAI partnership is no longer providing the edge it once did — a shift that comes as Google Cloud and Amazon Web Services also compete aggressively for AI workloads.

The meetings included senior Microsoft finance executives and covered monetization strategy, data center efficiency, and AI product rollouts.

A central topic was M365 Copilot. Management said adoption picked up strongly in the second half of FY2026, with weekly engagement now comparable to core tools like Outlook and Teams. Reback noted that customers are moving from small pilot projects to full-scale deployments — a meaningful shift that drove most of the optimism in his updated note. Broader enterprise adoption of AI productivity tools has been a key question for the industry, since converting pilots into paid, sustained usage is what determines whether AI investments translate into recurring software revenue.

Copilot and Pricing Strategy

Management also discussed its pricing approach. Microsoft is using a seat-plus-consumption model, and outcome-based pricing is not expected anytime soon. Premium upsells in M365 — including E5, M365 Copilot, and E7 — are driving moderate revenue acceleration. With seat growth leaning toward lower-priced tiers, management said average revenue per user from premium upgrades matters more than raw volume. The approach mirrors a broader software-industry shift toward usage-based components layered on top of traditional per-seat licensing.

Reback highlighted that management plans to be selective on pricing, mainly pushing increases in areas where Microsoft has a clear product advantage.

On capital spending, management said it is focused on improving data center efficiency to unlock more capacity for quick monetization. Reback noted this could limit margin pressure more than he had expected earlier this year.

Azure and Broader Wall Street View

Azure's growth rate climbed to 43% in Q4 FY2026, up from 39% the prior quarter, with guidance for Q1 FY2027 set at 45%. The re-acceleration matters because Azure growth is the metric most analysts treat as the clearest signal of Microsoft's AI demand, and Stifel's own upgrade thesis hinges on it.

BofA Securities raised its Microsoft price target to $600, citing Azure's acceleration and the company's AI growth strategy. KeyBanc maintained its Overweight rating and a $600 price target following Microsoft's recent segment reporting restatement.

Microsoft is also consolidating its three business segments into two for FY2027, a move aimed at better reflecting how management evaluates operations, particularly around AI infrastructure and cloud productivity.

Separately, Microsoft-backed G42, an Abu Dhabi-based AI firm, is exploring a multibillion-dollar fundraising round, though no final decisions have been made.

Wall Street overall holds a Strong Buy consensus on MSFT, with 32 Buy ratings and one Hold — a tally in which Stifel itself sits as the outlier. The average price target of $571.41 implies 14.4% upside from current levels. MSFT stock is up just 4% year-to-date, a muted gain that helps explain why analysts diverge on whether the stock has already priced in its AI momentum.